10-K Decoder · All companies

AngioDynamics, Inc.

ANGO · FY2026 · Fiscal year ended May 31, 2026 · 10-K filed Jul 2026

Open the dashboardInfographicSummary

FY2026 key figures

$FY2026FY2025Change
Revenue$320M$292M+9.5%
Operating income−$39.9M−$40.0M+0.1%
Net income−$36.7M−$34.0M−8.1%

Latest quarter: Q1 FY2027

Form 10-Q · Three months ended Aug 31, 2026 · filed Oct 8, 2026

$Q1 FY2027Year earlierChange
Revenue$80.9M$75.7M+6.9%
Operating income−$7.30M−$10.7M+31.8%
Net income−$7.10M−$10.9M+34.9%

Q1 FY2027 dashboardQ1 FY2027 infographic

Questions

What was AngioDynamics's revenue in FY2026?
$320M in FY2026 (Fiscal year ended May 31, 2026), +9.5% vs $292M a year earlier, per its 10-K filed Jul 2026.
Was AngioDynamics profitable in FY2026?
No: net income was −$36.7M and operating income −$39.9M in FY2026.
What was AngioDynamics's revenue in Q1 FY2027?
$80.9M (+6.9% vs a year earlier), per its Form 10-Q filed Oct 8, 2026.